These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 12111016

  • 1. The decision to accept treatment for osteoporosis following hip fracture: exploring the woman's perspective using a stage-of-change model.
    Mauck KF, Cuddihy MT, Trousdale RT, Pond GR, Pankratz VS, Melton LJ.
    Osteoporos Int; 2002 Jul; 13(7):560-4. PubMed ID: 12111016
    [Abstract] [Full Text] [Related]

  • 2. Health-economic comparison of three recommended drugs for the treatment of osteoporosis.
    Brecht JG, Kruse HP, Möhrke W, Oestreich A, Huppertz E.
    Int J Clin Pharmacol Res; 2004 Jul; 24(1):1-10. PubMed ID: 15575171
    [Abstract] [Full Text] [Related]

  • 3. Overcoming barriers to osteoporosis care in vulnerable elderly patients with hip fractures.
    Switzer JA, Jaglal S, Bogoch ER.
    J Orthop Trauma; 2009 Jul; 23(6):454-9. PubMed ID: 19550234
    [Abstract] [Full Text] [Related]

  • 4. Study of osteoporosis awareness, investigation and treatment of patients discharged from a tertiary public teaching hospital.
    Inderjeeth CA, Glennon D, Petta A.
    Intern Med J; 2006 Sep; 36(9):547-51. PubMed ID: 16911544
    [Abstract] [Full Text] [Related]

  • 5. An analysis of osteoporosis-related hip fractures using hospital discharge data.
    Rubin BR, René AA, Mains DA, Marshall MA.
    J Am Osteopath Assoc; 2003 Apr; 103(4):169-75. PubMed ID: 12733546
    [Abstract] [Full Text] [Related]

  • 6. Osteodensitometry in healthy postmenopausal women.
    Prescrire Int; 2008 Apr; 17(94):68-72. PubMed ID: 18536138
    [Abstract] [Full Text] [Related]

  • 7. Strontium ranelate: vertebral and non-vertebral fracture risk reduction.
    Seeman E.
    Curr Opin Rheumatol; 2006 Jun; 18 Suppl 1():S17-20. PubMed ID: 16735841
    [Abstract] [Full Text] [Related]

  • 8. [Raloxifene in clinical practice. Results of the non-interventional study CORAL (COmpliance with RALoxifene)].
    Rosa J, Vanuga P, Payer J, Svobodník A.
    Vnitr Lek; 2008 Mar; 54(3):217-9, 221-4. PubMed ID: 18522288
    [Abstract] [Full Text] [Related]

  • 9. Prevalence of depressive symptoms in postmenopausal women with low bone mineral density and/or prevalent vertebral fracture: results from the Multiple Outcomes of Raloxifene Evaluation (MORE) study.
    Silverman SL, Shen W, Minshall ME, Xie S, Moses KH.
    J Rheumatol; 2007 Jan; 34(1):140-4. PubMed ID: 17216681
    [Abstract] [Full Text] [Related]

  • 10. Use of clinical risk factors in elderly women with low bone mineral density to identify women at higher risk of hip fracture: The EPIDOS prospective study.
    Dargent-Molina P, Douchin MN, Cormier C, Meunier PJ, Bréart G, EPIDOS Study Group.
    Osteoporos Int; 2002 Jul; 13(7):593-9. PubMed ID: 12111021
    [Abstract] [Full Text] [Related]

  • 11. Bone mineral density thresholds for pharmacological intervention to prevent fractures.
    Siris ES, Chen YT, Abbott TA, Barrett-Connor E, Miller PD, Wehren LE, Berger ML.
    Arch Intern Med; 2004 May 24; 164(10):1108-12. PubMed ID: 15159268
    [Abstract] [Full Text] [Related]

  • 12. Low frequency of treatment of osteoporosis among postmenopausal women following a fracture.
    Andrade SE, Majumdar SR, Chan KA, Buist DS, Go AS, Goodman M, Smith DH, Platt R, Gurwitz JH.
    Arch Intern Med; 2003 Sep 22; 163(17):2052-7. PubMed ID: 14504118
    [Abstract] [Full Text] [Related]

  • 13. Use of a case manager to improve osteoporosis treatment after hip fracture: results of a randomized controlled trial.
    Majumdar SR, Beaupre LA, Harley CH, Hanley DA, Lier DA, Juby AG, Maksymowych WP, Cinats JG, Bell NR, Morrish DW.
    Arch Intern Med; 2007 Oct 22; 167(19):2110-5. PubMed ID: 17954806
    [Abstract] [Full Text] [Related]

  • 14. Identification of women at increased risk of osteoporosis: no need to use different screening tools at different ages.
    Dargent-Molina P, Piault S, Bréart G.
    Maturitas; 2006 Apr 20; 54(1):55-64. PubMed ID: 16202546
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Women with low-energy fracture should be investigated for osteoporosis.
    Löfman O, Hallberg I, Berglund K, Wahlström O, Kartous L, Rosenqvist AM, Larsson L, Toss G.
    Acta Orthop; 2007 Dec 20; 78(6):813-21. PubMed ID: 18236189
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A comprehensive review of treatments for postmenopausal osteoporosis.
    Häuselmann HJ, Rizzoli R.
    Osteoporos Int; 2003 Jan 20; 14(1):2-12. PubMed ID: 12577179
    [Abstract] [Full Text] [Related]

  • 19. The osteoporosis needs of patients with wrist fracture.
    Bogoch ER, Elliot-Gibson V, Escott BG, Beaton DE.
    J Orthop Trauma; 2008 Sep 20; 22(8 Suppl):S73-8. PubMed ID: 18753893
    [Abstract] [Full Text] [Related]

  • 20. Contribution of bone mineral density and bone turnover markers to the estimation of risk of osteoporotic fracture in postmenopausal women.
    Garnero P, Delmas PD.
    J Musculoskelet Neuronal Interact; 2004 Mar 20; 4(1):50-63. PubMed ID: 15615078
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.